Please do not adjust margins
ChemComm
Page 4 of 4
DOI: 10.1039/C7CC02948A
COMMUNICATION
Journal Name
2003, 302, 613; (d) M. D. Burke and S. L. Schreiber, Angew.
The introduction of the acryl amide moiety in 16b provided the
opportunity for further diversification through RCM of the
terminal olefin, and the spirocyclic product 17 was isolated in
78% yield (Scheme 1). Cross-metathesis (CM) reactions were
also investigated as a means of olefin functionalization, and
while substrates with R3 = CH2NHBoc only resulted in traces of
product, Hoveyda-Grubbs 2nd generation catalyst (H-G II) in
combination with copper(I)iodide9 efficiently promoted the
CM of 16e with ethyl acrylate to afford 18 in 74% yield.
Chem. Int. Ed., 2004, 43, 46; (e) T. E. Nielsen and S. L. Schreiber,
Angew. Chem. Int. Ed., 2008, 47, 48; (f) W. R. J. D. Galloway, A.
Isidro-Llobet and D. R. Spring, Nat. Commun., 2010, 1, 80; (g) S.
L. Schreiber, Proc. Natl. Acad. Sci. USA, 2011, 108, 6699; (h) A.
Nadin, C. Hattotuwagama and I. Churcher, Angew. Chem. Int.
Ed. Engl., 2012, 51, 1114; (i) R. Doveston, S. Marsden and A.
Nelson, Drug Discov Today, 2014, 19, 813; (j) H. van Hattum and
H. Waldmann, J. Am. Chem. Soc., 2014, 136, 11853.
5. (a) E. Ascic, J. F. Jensen and T. E. Nielsen, Angew. Chem. Int. Ed.,
2011, 50, 5188; (b) E. Ascic, S. T. Le Quement, M. Ishoey, M.
Daugaard and T. E. Nielsen, ACS Comb. Sci., 2012, 14, 253; (c) S.
T. Le Quement, T. Flagstad, R. J. T. Mikkelsen, M. R. Hansen, M.
C. Givskov and T. E. Nielsen, Org. Lett., 2012, 14, 640; (d) R.
Petersen, S. T. L. Quement and T. E. Nielsen, Angew. Chem. Int.
Ed., 2014, 53, 11778; (e) T. Flagstad, M. R. Hansen, S. T. Le
Quement, M. Givskov and T. E. Nielsen, ACS Comb. Sci., 2015,
17, 19; (f) T. Flagstad, M. R. Hansen, S. T. Le Quement, M.
Givskov and T. E. Nielsen, ACS Comb. Sci., 2014, 17, 19; (g) R. G.
Petersen, A. E. Cohrt, M. A. Petersen, P. Wu, M. H. Clausen and
T. E. Nielsen, Bioorg. Med. Chem., 2015, 23, 2646; (h) M. A.
Petersen, M. A. Mortensen, A. E. Cohrt, R. G. Petersen, P. Wu,
N. Fleury-Brégot, R. Morgentin, C. Lardy, T. E. Nielsen and M. H.
Clausen, Bioorg. Med. Chem., 2015, 23, 2695; (i) P. Wu, M. A.
Petersen, R. Petersen, T. Flagstad, R. Guilleux, M. Ohsten, R.
Morgentin, T. E. Nielsen and M. H. Clausen, RSC Adv., 2016, 6,
46654; (j) P. Wu, M. A. Petersen, A. E. Cohrt, R. Petersen, R.
Morgentin, H. Lemoine, C. Roche, A. Willaume, M. H. Clausen
and T. E. Nielsen, Org. Biomol. Chem., 2016, 14, 6947.
6. F. Garro-Helion, A. Merzouk and F. Guibé, J. Org. Chem., 1993,
58, 6109.
R1
H
H-G II, CuI
N
H
ethyl acrylate
CH2Cl2, reflux
Grubbs II
HO
R2
CH2Cl2, reflux
O
R2 = CH2NHCOCHCH2
R2 = H
16b or 15c
O
H
Ph
N
H
H
Ph
N
H
HO
HO
NH
O
O
O
18, 74%
17, 78%
CO2Et
Scheme 1: Functionalizaton of the terminal olefin via RCM and CM.
In summary, we have developed a concise strategy for the
synthesis of complex heterocyclic scaffolds utilizing a highly
diastereoselective tandem Petasis 3-CR/IMDA reaction in
combination with
incorporation of strategically positioned functional groups, we
have synthesized library of densely diversified small
a ROM-RCM sequence. Through the
a
7. D. B. C. Martin and C. D. Vanderwal, Chem. Sci., 2011, 2, 649.
8. B. C. Laguzza and B. Ganem, Tetrahedron Lett., 1981, 22, 1483.
9. K. Voigtritter, S. Ghorai and B. H. Lipshutz, J. Org. Chem., 2011,
76, 4697.
molecules that mimic the structural complexity of natural
products.
The research leading to these results has received support
from the Innovative Medicines Initiative Joint Undertaking
under grant agreement no. 115489, resources of which are
composed of financial contribution from the European Union’s
Seventh Framework Programme (FP7/2007-2013) and EFPIA
companies’ in-kind contribution. The Technical University of
Denmark is gratefully acknowledged for financial support and
we thank Associate Professor Pernille Harris for assistance with
X-ray crystallography
.
Notes and references
§ See NOESY assignments for 8b in ESI
.
1. R. Macarron, M. N. Banks, D. Bojanic, D. J. Burns, D. A. Cirovic, T.
Garyantes, D. V. S. Green, R. P. Hertzberg, W. P. Janzen, J. W.
Paslay, U. Schopfer and G. S. Sittampalam, Nat. Rev. Drug
Discovery, 2011, 10, 188.
2. (a) C. M. Dobson, Nature, 2004, 432, 824; (b) R. A. Bauer, J. M.
Wurst and D. S. Tan, Curr. Opin. Chem. Biol., 2010, 14, 308; (c) S.
Dandapani and L. A. Marcaurelle, Nat. Chem. Biol., 2010, 6, 861;
(d) C. J. O' Connor, H. S. G. Beckmann and D. R. Spring, Chem.
Soc. Rev., 2012, 41, 4444.
3. D. H. Drewry and R. Macarron, Curr. Opin. Chem. Biol., 2010, 14,
289.
4. (a) S. L. Schreiber, Science, 2000, 287, 1964; (b) R. Breinbauer, I.
R. Vetter and H. Waldmann, Angew. Chem. Int. Ed., 2002, 41,
2878; (c) M. D. Burke, E. M. Berger and S. L. Schreiber, Science,
4 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins